Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891092-06-001294
Filing Date
2006-05-19
Accepted
2006-05-19 17:24:28
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e24077_10k.htm 10-K 1394231
2 SECOND AMENDMENT AND WAIVER e24077ex10_8-2.htm EX-10.8.2 72804
3 SUBSIDIARIES OF BRADLEY PHARMACEUTICALS, INC. e24077ex21.htm EX-21 1780
4 CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM e24077ex23_1.htm EX-23.1 2048
5 SECTION 302 CERTIFICATION e24077ex31_1.htm EX-31.1 9002
6 SECTION 302 CERTIFICATION e24077ex31_2.htm EX-31.2 9024
7 SECTION 906 CERTIFICATION e24077ex32_1.htm EX-32.1 3132
8 SECTION 906 CERTIFICATION e24077ex32_2.htm EX-32.2 3094
  Complete submission text file 0000891092-06-001294.txt   1496497
Mailing Address 383 ROUTE 46 WEST FAIRFIELD NJ 08816
Business Address 383 RTE 46 WEST FAIRFIELD NJ 08816 9738821505
BRADLEY PHARMACEUTICALS INC (Filer) CIK: 0000864268 (see all company filings)

EIN.: 222581418 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31680 | Film No.: 06856235
SIC: 2834 Pharmaceutical Preparations